CompoAtlas

REPONSE CARDIOVASCULAIRE

Food supplement declared in France, declaration No 2019-3-957

REPONSE CARDIOVASCULAIRE is a food supplement declared in France. Status: retiré du marché le 16 December 2022. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
POLLENERGIE
Status
Retiré du marché le 16 December 2022
Form
Gélule
Daily dose
3 gélules
Directions for use
3 gélules de 530 mg par jour en 3 prises pendant les repas pendant 1 mois minimum.
Intended populations
Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims)
Artères et cholestérol

Declaration 212576, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Cynara scolymus L.FeuilleExtrait sec aqueux546 mg
Monascus purpureus WentMycéliumPoudre (de plantes séchées ou broyées)486 mg
Allium sativum L.BulbeAutre extrait sec40.5 mg

Other active ingredients

NamePer day
Propolisnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E414

Other ingredients

Gélatine de poisson

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l'adulte. Déconseillé aux femmes enceintes ou allaitantes, aux personnes intolérantes aux statines, aux personnes allergiques aux produits de la ruche.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line